Do current economic evaluations fully capture vaccine value: a review of evidence from India [0.03%]
当前的经济评估能否全面地反映疫苗的价值？基于印度证据的综述分析
Navneet Kaur,Joseph L Mathew,Madhu Gupta et al.
Navneet Kaur et al.
Introduction: Traditional economic evaluations typically focus on direct health effects and costs offset to the healthcare system. However, vaccines offer significant indirect benefits beyond direct health effects, such a...
Cost-effectiveness of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing device for treatment of heavy menstrual bleeding: a systematic review [0.03%]
子宫切除术、宫腔内放置左炔诺孕酮系统及一、二代子宫内膜消融术治疗月经过多的成本效益分析：一项系统综述
Asal Sadat Niaraees Zavare,Aziz Rezapour,Aghdas Souresrafil et al.
Asal Sadat Niaraees Zavare et al.
Objectives: This study aims to provide a clear understanding of the relative economic evaluation of hysterectomy, first- and second-generation endometrial ablation, and levonorgestrel-releasing intrauterine device for tre...
The hidden burden of atopic dermatitis in central and Eastern European countries [0.03%]
中欧和东欧国家特应性皮炎的隐形负担
Baher Elezbawy,Zoltán Kaló,Ahmad Fasseeh et al.
Baher Elezbawy et al.
Background: Atopic dermatitis (AD) imposes a hidden burden through its negative effects on quality of life and productivity. We aim to estimate this hidden burden in adults and adolescents in Central and Eastern European ...
How can patients shape digital medicine? A rapid review of patient and public involvement and engagement in the development of digital health technologies for neurological conditions [0.03%]
患者如何塑造数字医学？一种关于神经性疾病数字健康技术开发中的患者和公众参与和互动的快速综述
Megan Hanrahan,Cameron Wilson,Alison Keogh et al.
Megan Hanrahan et al.
Introduction: Patient and Public Involvement and Engagement (PPIE) involves working 'with' or 'by' patients and the public, rather than 'to,' 'about,' or 'for' them, and is integral to neurological and digital health rese...
Estimated value of productivity lost due to childhood chickenpox in the United Kingdom: a survey of parents [0.03%]
英国儿童因患水痘造成的生产力损失估计值：一项针对家长的调查研究
Raphael Wittenberg,Jacqueline Damant,Amritpal Rehill et al.
Raphael Wittenberg et al.
Background: While medical costs of chickenpox have been researched, little is known about indirect costs. Understanding total costs is important for decisions about vaccination. This study estimated the value of lost prod...
Impact of patient's financial burden of COVID-19 treatment on antiviral prescription rates and clinical and economic outcomes [0.03%]
患者新冠肺炎治疗经济负担对抗病毒药物处方率及临床和经济效益的影响分析
Mitsuhiro Nagano,Sachiko Hyokai,Kanae Togo et al.
Mitsuhiro Nagano et al.
Background: In Japan, medical expenses for COVID-19 treatment transitioned from full public funding support to out-of-pocket (OOP) payment by patients plus partial public support in October 2023, and public support fully ...
Analysis of prescriptive monitoring regarding the current therapeutic landscape of rheumatoid arthritis: the experience of an Italian local health authority [0.03%]
意大利地方卫生局关于规范性监测的分析：当前治疗类风湿关节炎的格局经验
Francesco Ferrara,Andrea Zovi,Roberto Langella et al.
Francesco Ferrara et al.
Introduction: Rheumatoid Arthritis (RA) is among the most prevalent chronic inflammatory diseases affecting millions of people with a significant expenditure of resources by National Healthcare Systems. This study aimed t...
Cost-utility analysis of duloxetine in osteoarthritis: from Chinese healthcare perspective [0.03%]
从中国医疗保健的角度分析杜洛西汀治疗骨关节炎的成本效用
Xueshan Sun,Xuemei Zhen,Shuyan Gu et al.
Xueshan Sun et al.
Objectives: To estimate the cost-utility of duloxetine compared with that of a placebo, common traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 (COX-2) inhibitors for the treatment of osteoar...
Cost-effectiveness of first-line sintilimab plus chemotherapy versus chemotherapy for advanced esophageal carcinoma in China [0.03%]
替雷利珠单抗联合化疗对比单纯化疗作为晚期食管癌一线治疗的卫生经济学价值分析
Nanlong Lin,Shiting Chen,Zhiwei Zheng et al.
Nanlong Lin et al.
Background: To evaluate the cost-effectiveness of first-line sintilimab plus chemotherapy versus chemotherapy for advanced esophageal squamous cell carcinoma (ESCC) from the perspective of the Chinese health service syste...
Perceptions of risk sharing agreements in South Korea from the viewpoints of key stakeholders: a convergent parallel mixed approach [0.03%]
利益相关者视角下韩国风险分担协议的认知状况——兼论混合研究方法的收敛平行模式
Tae-Jin Lee,Kyung-Bok Son
Tae-Jin Lee
Objectives: In 2013, South Korea introduced risk-sharing agreements (RSAs) as a new reimbursement mechanism to enhance access to new medicines and to manage pharmaceutical expenditures. This study evaluates RSAs in South ...